This systematic review aimed to provide an overview of the weight loss efficacy and adverse event profile of GLP-1 RAs in two populations: adults with overweight/obesity with and without T2DM. This evidence concerns the gene GLP1R and obesity due to melanocortin 4 receptor deficiency.